Top

The International Journal of Cardiovascular Imaging

Published in:

01-12-2013

The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease

Authors: Sophie Mavrogeni, George Papadopoulos, Tarique Hussain, Amedeo Chiribiri, Rene Botnar, Gerald F. Greil

Published in: The International Journal of Cardiovascular Imaging | Issue 8/2013

Abstract

Kawasaki disease (KD) is a vasculitis affecting the coronary and systemic arteries. Myocardial inflammation is also a common finding in KD post-mortem evaluation during the acute phase of the disease. Coronary artery aneurysms (CAAs) develop in 15–25 % of untreated children. Although 50–70 % of CAAs resolve spontaneously 1–2 years after the onset of KD, the remaining unresolved CAAs can develop stenotic lesions at either their proximal or distal end and can develop thrombus formation leading to ischemia and/or infarction. Cardiovascular magnetic resonance (CMR) has the ability to perform non-invasive and radiation-free evaluation of the coronary artery lumen. Recently tissue characterization of the coronary vessel wall was provided by CMR. It can also image myocardial inflammation, ischemia and fibrosis. Therefore CMR offers important clinical information during the acute and chronic phase of KD. In the acute phase, it can identify myocardial inflammation, microvascular disease, myocardial infarction, deterioration of left ventricular function, changes of the coronary artery lumen and changes of the coronary artery vessel wall. During the chronic phase, CMR imaging might be of value for risk stratification and to guide treatment.

Kim and Goo [75].

Taubert KA, Rowley AH, Shulman ST (1994) Seven-year national survey of Kawasaki disease and acute rheumatic fever. Pediatr Infect Dis J 13:704–708PubMedCrossRef

Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, Shulman ST, Bolger AF, Ferrieri P, Baltimore RS, Wilson WR, Baddour LM, Levison ME, Pallasch TJ, Falace DA, Taubert KA (2004) A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708–1733PubMedCrossRef

Naoe S, Takahashi K, Masuda H, Tanaka N (1991) Kawasaki disease: with particular emphasis on arterial lesions. Acta Pathol Jpn 41:785–797PubMed

Yoshikawa H, NomuraY Y, Masuda K, Hazeki D, Yotsumoto K, Arata M, Kamenosono A, Yanagi S, Yoshinaga M, Kawano Y (2006) Four cases of Kawasaki syndrome complicated with myocarditis. Circ J 70:202–205PubMedCrossRef

Shinohara T, Yokoyama T (1999) Clinical study of cardiac pump failure in acute phase of Kawasaki disease. J Pediatr Pract 62:2101–2104

Mavrogeni S, Bratis K, Karanasios E, Georgakopoulos D, Kaklis S, Varlamis G, Kolovou G, Douskou M, Papadopoulos G (2011) Cardiovascular magnetic resonance evaluation of cardiac involvement during the convalescence phase of Kawasaki disease. JACC Cardiovasc Imag 4(10):1140–1141CrossRef

Porcalla AR, Sable CA, Patel KM, Martin GR, Singh N (2005) The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms? Pediatr Cardiol 26:775–781PubMedCrossRef

Akagi T, Rose V, Benson LN, Newman A, Freedom RM (1992) Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr 121:689–694PubMedCrossRef

Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H (1992) Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet 340:1127–1129PubMedCrossRef

10.

Burns JC, Gordon JB, Malhora A, Schoenwetter M, Kawasaki T (1996) Sequelae of Kawasaki disease in adolescents and young adults. J Am Coll Cardiol 28:253–257PubMedCrossRef

11.

Capannari TE, Daniels SR, Meyer RA, Schwartz DC, Kaplan S (1986) Sensitivity, specificity and predictive value of two-dimensional echocardiography in detecting coronary artery aneurysms in patients with Kawasaki disease. J Am Coll Cardiol 7:355–360PubMedCrossRef

12.

Hiraishi S, Misawa H, Takeda N, Horiguchi Y, Fujino N, Ogawa N, Hirota H (2000) Transthoracic ultrasonic visualisation of coronary aneurysm, stenosis, and occlusion in Kawasaki disease. Heart 83:400–405PubMedCrossRef

13.

Albro PC, Gould KL, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL (1978) Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. Am J Cardiol 42:751–760PubMedCrossRef

14.

Mason JR, Palac RT, Freeman ML, Virupannavar S, Loeb HS, Kaplan E, Gunnar RM (1984) Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. Am Heart J 107:481–485PubMedCrossRef

15.

Kondo C, Hiroe M, Nakanishi T, Takao A (1989) Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201TI myocardial tomography. Circulation 80:615–624PubMedCrossRef

16.

Bergersen L, Gauvreau K, Marshall A, Kreutzer J, Beekman R, Hirsch R, Foerster S, Balzer D, Vincent J, Hellenbrand W, Holzer R, Cheatham J, Moore J, Lock J, Jenkins K (2011) Procedure-type risk categories for pediatric and congenital cardiac catheterization. Circ Cardiovasc Interv 4:188–194PubMedCrossRef

17.

Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, Nikolaidou P, Bakoula C, Karanasios E, Manginas A, Cokkinos DV (2004) Magnetic resonance angiography is equivalent to x-ray coronary angiography for the evaluation of the coronary arteries in Kawasaki disease. J Am Coll Cardiol 43:649–652PubMedCrossRef

18.

Greil GF, Stuber M, Botnar RM, Kissinger KV, Geva T, Newburger JW, Manning WJ, Powell AJ (2002) Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 105(8):908–911PubMedCrossRef

19.

Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, Langerak SE, Weber OM, Pedersen EM, Schmidt M, Botnar RM, Manning WJ (2001) Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med 345:1863–1869PubMedCrossRef

20.

Post JC, van Rossum AC, Bronzwaer JG, de Cock CC, Hofman MB, Valk J, Visser CA (1995) Magnetic resonance angiography of anomalous coronary arteries. A new gold standard for delineating the proximal course? Circulation 92:3163–3171PubMedCrossRef

21.

Lee DC, Simonetti OP, Harris KR, Holly TA, Judd RM, Wu E, Klocke FJ (2004) Magnetic resonance versus radionuclide pharmacological stress perfusion imaging for flow-limiting stenoses of varying severity. Circulation 110:58–65PubMedCrossRef

22.

Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM (2003) Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 361:374–379PubMedCrossRef

23.

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, Bijsterveld P, Ridgway JP, Radjenovic A, Dickinson CJ, Ball SG, Plein S (2012) Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 379(9814):453–460PubMedCrossRef

24.

Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453PubMedCrossRef

25.

Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV (2008) How to image Kawasaki disease: a validation of different imaging techniques. Int J Cardiol 124(1):27–31PubMedCrossRef

26.

Greil GF, Seeger A, Miller S, Claussen CD, Hofbeck M, Botnar RM, Sieverding L (2007) Coronary magnetic resonance angiography and vessel wall imaging in children with Kawasaki disease. Pediatr Radiol 37(7):666–673PubMedCrossRef

27.

Uribe S, Hussain T, Valverde I, Tejos C, Irarrazaval P, Fava M, Beerbaum P, Botnar RM, Razavi R, Schaeffter T, Greil GF (2011) Congenital heart disease in children: coronary MR angiography during systole and diastole with dual cardiac phase whole-heart imaging. Radiology 260:232–240PubMedCrossRef

28.

Pedersen SF, Thrysøe SA, Paaske WP, Thim T, Falk E, Ringgaard S, Kim WY (2011) Determination of oedema in porcine coronary arteries by T2 weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson 13:52PubMedCrossRef

29.

Tangcharoen T, Bell A, Hegde S, Hussain T, Beerbaum P, Schaeffter T, Razavi R, Botnar RM, Greil GF (2011) Detection of coronary artery anomalies in infants and young children with congenital heart disease by using MR imaging. Radiology 259:240–247PubMedCrossRef

30.

Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Varlamis G, Karanasios E, Krikos X, Giannoulia A, Cokkinos DV (2006) Magnetic resonance angiography, function and viability evaluation in patients with Kawasaki disease. J Cardiovasc Magn Reson 8(3):493–498PubMedCrossRef

31.

Halliburton S, Arbab-Zadeh A, Dey D, Einstein AJ, Gentry R, George RT, Gerber T, Mahesh M, Weigold WG (2012) State-of-the-art in ct hardware and scan modes for cardiovascular CT. J Cardiovasc Comput Tomogr 6:154–163PubMedCrossRef

32.

Han BK, Lindberg J, Grant K, Schwartz RS, Lesser JR (2011) Accuracy and safety of high pitch computed tomography imaging in young children with complex congenital heart disease. Am J Cardiol 107:1541–1546PubMedCrossRef

33.

Harada M, Yokouchi Y, Oharaseki T, Matsui K, Tobayama H, Tanaka N, Akimoto K, Takahashi K, Kishiro M, Shimizu T, Takahashi K (2012) Histopathological characteristics of myocarditis in acute-phase Kawasaki disease. Histopathology 61(6):1156–1167PubMedCrossRef

34.

Mavrogeni S, Spargias K, Markussis V, Kolovou G, Demerouti E, Papadopoulou E, Stavridis G, Kaklamanis L, Douskou M, Constantoulakis P, Cokkinos DV (2009) Myocardial inflammation in autoimmune diseases: investigation by cardiovascular magnetic resonance and endomyocardial biopsy. Inflamm Allergy Drug Targets 8(5):390–397PubMedCrossRef

35.

Abdel-Aty H, Boye P, Zagrosek A, Wassmuth R, Kumar A, Messroghli D, Bock P, Dietz R, Friedrich MG, Schulz-Menger J (2005) Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 45:1815–1822PubMedCrossRef

36.

Mavrogeni S, Papadopoulos G, Karanasios E, Cokkinos DV (2009) Cardiovascular magnetic resonance imaging reveals myocardial inflammation and coronary artery ectasia during the acute phase of Kawasaki disease. Int J Cardiol 136(3):e51–e53PubMedCrossRef

37.

Itamura S, Kamada M, Nakagawa N (2011) Kawasaki disease complicated with reversible splenial lesion and acute myocarditis. Pediatr Cardiol 32(5):696–699PubMedCrossRef

38.

Cunha BA, Pherez FM, Alexiadis V, Gagos M, Strollo S (2010) Adult Kawasaki’s disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels. Heart Lung 39(2):164–172PubMedCrossRef

39.

Tacke CE, Kuipers IM, Groenink M, Spijkerboer AM, Kuijpers TW (2011) Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imag 4(6):712–720CrossRef

40.

Silvera S, Strach K, Bogaert J, Sommer T, Vignaux O (2011) Cardiomyopathies (hypertrophy and failure): what can offer cardiac magnetic resonance imaging? Presse Med 40(9 Pt 2):e425–e436PubMedCrossRef

41.

Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, Mohan V, Becker LC, Zerhouni EA (1995) Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. Circulation 92:1902–1910PubMedCrossRef

42.

Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002PubMedCrossRef

43.

Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM (2000) Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 36:1985–1991PubMedCrossRef

44.

45.

Kaandorp TA, Lamb HJ, Poldermans D, Viergever EP, Boersma E, van der Wall EE, de Roos A, Bax JJ (2007) Assessment of right ventricular infarction with contrast-enhanced magnetic resonance imaging. Coron Artery Dis 18:39–43PubMedCrossRef

46.

Kumar A, Abdel-Aty H, Kriedemann I, Schulz-Menger J, Gross CM, Dietz R, Friedrich MG (2006) Contrast enhanced cardiovascular magnetic resonance imaging of right ventricular infarction. J Am Coll Cardiol 48:1969–1976PubMedCrossRef

47.

Larose E, Ganz P, Reynolds HG, Dorbala S, Di Carli MF, Brown KA, Kwong RY (2007) Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol 49:855–862PubMedCrossRef

48.

Wu YW, Tadamura E, Kanao S, Yamamuro M, Marui A, Komeda M, Toma M, Kimura T, Togashi K (2007) Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography. Int J Cardiovasc Imag 23(6):757–765CrossRef

49.

Kwong RY, Chan AK, Brown KA et al (2006) Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 113:2733–2743PubMedCrossRef

50.

Sato Y, Matsumoto N, Komatsu S, Kunimasa T, Tani S, Imazeki T, Anazawa T, Kasamaki Y, Kunimoto S, Takahashi M, Saito S (2007) Coronary artery abnormalities after Kawasaki disease in an adult: depiction at whole heart coronary magnetic resonance angiography. Int J Cardiol 116(3):396–398PubMedCrossRef

51.

Yoon YE, Kitagawa K, Kato S, Ishida M, Nakajima H, Kurita T, Ito M, Sakuma H (2012) Prognostic value of coronary magnetic resonance angiography for prediction of cardiac events in patients with suspected coronary artery disease. J Am Coll Cardiol 60(22):2316–2322PubMedCrossRef

52.

Ibrahim T, Makowski MR, Jankauskas A, Maintz D, Karch M, Schachoff S, Manning WJ, Schömig A, Schwaiger M, Botnar RM (2009) Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. JACC Cardiovasc Imag 2(5):580–588CrossRef

53.

Kim WY, Stuber M, Börnert P, Kissinger KV, Manning WJ, Botnar RM (2002) Three-dimensional black-blood cardiac magnetic resonance coronary vessel wall imaging detects positive arterial remodeling in patients with nonsignificant coronary artery disease. Circulation 106(3):296–299PubMedCrossRef

54.

Doesch C, Seeger A, Doering J, Herdeg C, Burgstahler C, Claussen CD, Gawaz M, Miller S, May AE (2009) Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. JACC Cardiovasc Imag 2(4):424–433CrossRef

55.

Kramer C, Barkhausen J, Flamm S, Kim R, Nagel E (2008) Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustes task force on standardized protocols. J Cardiovasc Magn Reson 10:35PubMedCrossRef

56.

Luechinger R, Scwitter J (2008) CMR update. J Schwitter Switz 30–41

57.

Kozerke S, Tsao J (2004) Reduced data acquisition methods in cardiac imaging. Top Magn Reson Imag 15:161–168CrossRef

58.

Rangamani S, Varghese J, Li L, Harvey L, Hammel JM, Fletcher SE, Duncan KF, Danford DA, Kutty S (2012) Safety of cardiac magnetic resonance and contrast angiography for neonates and small infants: a 10-year single-institution experience. Pediatr Radiol 42(11):1339–1346PubMedCrossRef

59.

Lockie T, Ishida M, Perera D, Chiribiri A, De Silva K, Kozerke S, Marber M, Nagel E, Rezavi R, Redwood S, Plein S (2011) High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 57:70–75PubMedCrossRef

60.

Hautvast GLTF, Chiribiri A, Lockie T, Breeuwer M, Nagel E, Plein S (2011) Quantitative analysis of transmural gradients in myocardial perfusion magnetic resonance images. Magn Res Med 66:1477–1487CrossRef

61.

Chiribiri A, Hautvast GLTF, Lockie T, Schuster A, Bigalke B, Olivotti L, Redwood SR, Breeuwer M, Plein S, Nagel E (2013) Quantitative analysis of transmural perfusion gradients by high-resolution magnetic resonance versus fractional flow reserve for the assessment of coronary artery stenosis severity and location. JACC Cardiovasc Imag 6:600–609CrossRef

62.

Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, Simonetti OP (2009) T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11:56PubMedCrossRef

63.

Verhaert D, Thavendiranathan P, Giri S, Mihai G, Rajagopalan S, Simonetti OP, Raman SV (2011) Direct t2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imag 4(3):269–278CrossRef

64.

Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ (2008) Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52:1574–1580PubMedCrossRef

65.

Ladd SC, Debatin JF, Stang A, Bromen K, Moebus S, Nuefer M, Gizewski E, Wanke I, Doerfler A, Ladd ME, Benemann J, Erbel R, Forsting M, Schmermund A, Jöckel KH (1035) Whole-body MR vascular screening detects unsuspected concomitant vascular disease in coronary heart disease patients. Eur Radiol 2007(17):1035–1045

66.

Papini GD, Di Leo G, Tritella S, Nano G, Cotticelli B, Clemente C, Tealdi DG, Sardanelli F (2011) Evaluation of inflammatory status of atherosclerotic carotid plaque before thromboendarterectomy using delayed contrast-enhanced subtracted images after magnetic resonance angiography. Eur J Radiol 80(3):e373–e380PubMedCrossRef

67.

Cheng AS, Pegg TJ, Karamitsos TD, Searle N, Jerosch-Herold M, Choudhury RP, Banning AP, Neubauer S, Robson MD, Selvanayagam JB (2007) Cardiovascular magnetic resonance perfusion imaging at 3-Tesla for the detection of coronary artery disease: a comparison with 1.5-Tesla. J Am Coll Cardiol 49:2440–2449PubMedCrossRef

68.

Gutberlet M, Schwinge K, Freyhardt P, Spors B, Grothoff M, Denecke T, Lüdemann L, Noeske R, Niendorf T, Felix R (2005) Influence of high magnetic field strengths and parallel acquisition strategies on image quality in cardiac 2d cine magnetic resonance imaging: comparison of 1.5 t vs. 3.0 t. Eur Radiol 15:1586–1597PubMedCrossRef

69.

Lee HL, Shankaranarayanan A, Pohost GM, Nayak KS (2010) Improved coronary MR angiography using wideband steady state free precession at 3 Tesla with submillimeter resolution. J Magn Reson Imag 31(5):1224–1229CrossRef

70.

Liu X, Bi X, Huang J, Jerecic R, Carr J, Li D (2008) Contrast-enhanced whole-heart coronary magnetic resonance angiography at 3.0 T: comparison with steady-state free precession technique at 1.5 t. Invest Radiol 43:663–668PubMedCrossRef

71.

72.

Chapon C, Lemaire L, Franconi F, Marescaux L, Legras P, Denizot B, Le Jeune JJ (2004) Assessment of myocardial viability in rats: evaluation of a new method using superparamagnetic iron oxide nanoparticles and Gd-DOTA at high magnetic field. Magn Reson Med 52(4):932–936PubMedCrossRef

73.

Wu YL, Ye Q, Sato K, Foley LM, Hitchens TK, Ho C (2009) Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance. JACC Cardiovasc Imag 2(6):731–741CrossRef

74.

Richards JM, Semple SI, MacGillivray TJ, Gray C, Langrish JP, Williams M, Dweck M, Wallace W, McKillop G, Chalmers RT, Garden OJ, Newby DE (2011) Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study. Circ Cardiovasc Imag 4(3):274–281CrossRef

75.

Kim JW, Goo HW (2013) Coronary artery abnormalities in Kawasaki disease: comparison between ct and mr coronary angiography. Acta Radiol 54:156–163PubMedCrossRef

Title: The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease
Authors: Sophie Mavrogeni
George Papadopoulos
Tarique Hussain
Amedeo Chiribiri
Rene Botnar
Gerald F. Greil
Publication date: 01-12-2013
Publisher: Springer Netherlands
Published in: The International Journal of Cardiovascular Imaging / Issue 8/2013
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-013-0276-9

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2013

Erratum to: Neointimal coverage and vasodilator response to titanium-nitride-oxide-coated bioactive stents and everolimus-eluting stents in patients with acute coronary syndrome: insights from the BASE-ACS trial

Simple prediction of right ventricular ejection fraction using tricuspid annular plane systolic excursion in pulmonary hypertension

Preprocedural coronary CT angiography significantly improves success rates of PCI for chronic total occlusion

Cardiac magnetic resonance-derived right ventricular outflow tract systolic flow acceleration: a novel index of right ventricular function and prognosis in patients with pulmonary arterial hypertension

Scanning electron microscopic analysis of polymer damage in drug-eluting stents during multiple stenting

A novel approach for assessing cardiac fibrosis using label-free second harmonic generation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page